Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

M Hassanein, W Hanif, Waqar Malik, Ali Kamal, P Geransar, N Lister, C Andrews, Anthony Barnett

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective: To compare the incidence of hypoglycaemic events (HEs) in a real-world setting in Muslim patients with type 2 diabetes mellitus fasting during Ramadan. Research design and methods: We performed a
Original languageEnglish
Pages (from-to)1367-1374
Number of pages8
JournalCurrent Medical Research and Opinion
Volume27
Issue number7
DOIs
Publication statusPublished - 1 Jul 2011

Keywords

  • Diabetes mellitus, type 2
  • Dipeptidyl-peptidase 4 inhibitors
  • Fasting hypoglycaemia
  • Vildagliptin
  • Muslims

Fingerprint

Dive into the research topics of 'Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study'. Together they form a unique fingerprint.

Cite this